NR3C2 and Encephalopathy: Some authors reported no difference in the glucocorticoid and mineralocorticoid receptors in the hippocampus of SHRs and normotensive WKY rats [48], whereas others found increased mineralocorticoid receptor expression in the hippocampus of SHRs and considered this fact a reason for the development of encephalopathy [49].